ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002

FDA Forms Office of Combination Products;

January 10, 2003

Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications

March 18, 1977

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

ACS Probably Will Accept Hammer’s Offer On Matching Funds For Survey

February 3, 1984

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

August 1, 1997